DUPHAT Speakers

Abdullah Molokhia

Professor, Pharmaceutics Former Vice President for Research, Pharco Corporation Former Chairman, National Organization for Drug Control And Research | Egypt

Prof. Molokhia obtained his PhD from the University of Michigan, USA 1973. He held academic positions at Universities of Houston, Riyadh and Alexandria and is a current member of the Egyptian National Pharmacology Committee. He advised more than 52 PhD and MS candidates and co-authored more than 158 original manuscripts and presentations to national and international conferences. Between 1996-2004, he was the chairman of the Egyptian National Organization for Drug Control and Research at the Ministry of Health. From 2004 until 2013, he chaired the European Egyptian Pharmaceutical Industries Company, a division of Pharco Pharmaceuticals, Alexandria, Egypt. Between 2007-2013, he chaired the Pharmaceutical Sector of the Pharmaceuticals and Cosmetic Chamber at the Egyptian Industry Union. Prof. Molokhia chaired several conferences organized among NODCAR, the MOH and the WHO. As consultant to the WHO, he presented training and consultations to nine countries in the EMRO region. Prof. Molokhia co-chaired 5 Egyptian-USP Symposia on “Science and Standards”. He acts as observer representing the Egyptian Chamber of Pharmaceuticals with the USP Convention.

Ahmed Al Saqer, BPharm, MClin Pharm, MBA, BCPS, CDE

Consultant Clinical Pharmacist, Internal Medicine, John Hopkins Aramco Healthcare, AlAhssa, Saudi Arabia | Saudi Arabia

-

Albert Wertheimer, PhD, MBA

Nova Southeastern University College of Pharmacy, Florida, | USA

-

Andrew Ustianowski

Consultant Physician, Infectious Diseases & Tropical Medicine, North Western Regional Infection Unit | United Kingdom

Professor Andrew Ustianowski is a Consultant Physician in Infectious Diseases and Tropical Medicine at the North Western Regional Infection Unit, North Manchester General Hospital, UK, the Deputy Clinical Director in Greater Manchester Clinical Research Network and Joint National Specialty Lead for Infection for the UK National Institute of Health Research. Currently he is the national lead for the clinical workstream for the UK National COVID Vaccine Research Programme, is UK chief investigator on 6 COVID studies and has been an investigator on multiple other COVID studies Dr Ustianowski graduated from Guy’s Hospital, London, UK and subsequently trained in Infectious Diseases, Tropical Medicine, HIV and General Medicine in the London region.

Barry A. Bleidt

Professor, Sociobehavioral and Administrative Sciences, College of Pharmacy | USA

Dr. Bleidt is a Professor of Sociobehavioral and Administrative Pharmacy at Nova Southeastern University. He received his BS Pharmacy from the University of Kentucky, PhD in Pharmacy Healthcare Administration from the University of Florida, and his PharmD from Xavier University of Louisiana. Barry has forty years of professional experience in preventing drug use problems and substance misuse. Dr. Bleidt served fourteen years as Chair of the Program Committee for the Alcohol, Tobacco, and Other Drugs Section of the American Public Health Association and five years for the Pharmacy Section, twenty-three years as the parliamentarian of the American Association of Colleges of Pharmacy, and twenty-one years as the Director of Continuing Pharmacy Education for the National Pharmaceutical Association. He has served as a Delegate to the United States Pharmacopoeia Convention since 1985. Dr. Bleidt has delivered over 400 presentations and published nearly fifty works. Some of his publications include the books: Clinical Research in Pharmaceutical Development, Multicultural Pharmaceutical Education, and A Guide to the Top 200 Drugs. Dr. Bleidt was inducted as a Fellow into the APhA Academy of Pharmaceutical Research and Science in 2015. He received the 2013 Chauncey I Cooper Award (the highest honor bestowed by NPhA), 2007 Award for Innovative and Exemplary Contributions to the NPhA Foundation, the Ilene B. Stiff Local Association President’s Award as the leader of the Virginia Pharmacists Association Local Association of the Year (2001), the James M. Tyson Award (2nd Highest Honor from NPhA (2001);and the American Public Health Association Leadership Award from the Alcohol, Tobacco, and Other Drugs Section (2000). He currently resides in Ft. Lauderdale, Florida.

Christopher R. Fortier, PharmD, FASHP

Chief Pharmacy Officer, Massachusetts General Hospital | USA

-

David Lilienfeld, MD, MPH, MSEngin, FISPE, FACE

Principal, Write for the Pharm, LLC | USA

-

Dieter Steinhilber

President | Germany

Prof. Dr. Dieter Steinhilber, born 1959, studied pharmacy at the University of Tübingen. After an assistantship there he spent a postdoc period with Prof. Bengt Samuelsson, Karolinska Institute, Stockholm from 1989 until 1991. In 1994 he received an associated professorship and since 2000 he is a full professor for Pharmaceutical Chemistry at the Johann Wolfgang Goethe University in Frankfurt am Main. From 1999 until 2008 he was the Director of this Institute. From 1999 to 2000 he was Dean of the faculty Biochemistry, Pharmacy and Food Chemistry and from 2008-2011 he was Dean of the Faculty Biochemistry, Chemistry and Pharmacy. Prof Steinhilber is the speaker of the International Research Training Group "Dr. Hans Kröner Graduiertenkolleg" funded by the Else Kröner Fresenius-Stiftung. Since 2007, he is also the chairman of the graduate centre FIRST. In 2002, he has been elected into the board of ZAFES. Since 2002 he is a member of the "Wehrmedizinischer Beirat" and from 2004-2012, he was a member of the "DFG-Fachkollegium Medicine" and represented the Pharmaceutical Sciences in the board. Since 2005, he is chairman of the "Akademie für Pharmazeutische Weiterbildung der LAK Hessen". He was president of the German Pharmaceutical Society (DPhG) from 2012-2015 and since 2019 he is the President of EUFEPS. Since 2015, he is the head of the Research Area "Drug Identification and Formulation" at Fraunhofer IME-TMP.

Emad Elazazy

Prof. of Governance and Pharmaceutical Practices, President of VALUE Institution for Post-graduate Education, Vice President & Secretary General | Egypt

Prof. Emad Elazazy Prof. of Governance and Pharmaceutical Practices, President of VALUE Institution for Post-graduate Education, Vice President & Secretary General | Egypt

Eric Maroyka, PharmD,BCPS

Senior Director, Center on Pharmacy Practice Advancement , ASHP | USA

-

Fadilah Aleanizy, Ph.D.

College of Pharmacy, King Saud University Riyadh, Saudi Arabia | Saudi Arabia

-

Faisal A. Sehli, Pharm.D., MHSQM

King Abdulaziz Medical City National Guard Hospital, Ministry of National Guard, Riyadh, | Saudi Arabia

-

Faisal Alqarni, Pharm.D., BCPS, BCCP

Cardiology Clinical Pharmacist, Security Forces Hospital , Riyadh, Saudi Arabia | Saudi Arabia

-

Frank Lichtenberg, PhD

Columbia University Graduate School of Business; a Research Associate of the National Bureau of Economic Research, | USA

-

Fulwah Alqahtani, Ph.D.

College of Pharmacy, King Saud University Riyadh, Saudi Arabia | Saudi Arabia

-

Gabriel Jipa, Ph.D.

AI Expert, Senior Director IT Partner in Viatris and former IBM, HP Cognitive Solutions Team for Europe, | Romania

-

Ibrahim Al-Khars

Co-Founder & Chief Executive Officer of Afaq Alwataniyah Company and the Managing Director/Senior Consultant | Saudi Arabia

Dr. Al-Khars has a Master in Applied Business Research from Swiss Business School, Switzerland; a Master in Business Administration specialized in International Business from the University of Florida, USA and a special diploma degree in new venture creation from the same university. He received a Bachelor degree in Pharmaceutical Science from King Saud University, Riyadh, Saudi Arabia with honor and Master Degree in Clinical Pharmacy from the same university. His academic history includes a Specialty Residency in Pharmacy Practice Management at Detroit Receiving Hospital and Wayne State University, Detroit, Michigan, USA. His research interests include health care quality improvement, health care reform, the economic evaluation of treatment strategies, health care educational system and technologies, and pharmacy practice management. In addition to his teaching and management activities, Dr. Al-Khars has conducted many presentations, executive seminars and management development programs in different countries including Saudi Arabia, USA, Germany, Malaysia, Lebanon, Oman, Egypt, and United Arab Emirates.

Jorge Félix, Pharm.D., MSc.

Director of Exigo & Faculty of Pharmacy University of Lisbon, | Portugal

-

Lynnae M. Mahaney, BSPharm, MBA, FASHP

Senior Director, Pharmacy Accreditation ASHP | USA

-

Mag. Marko Skelin,

Chair for the Essential requirements for quality in cancer care (ERQCC), Croatia & Member, Board of Directors, ESOP, Croatia. | Croatia

-

Marc Evans

Consultant Diabetologist, University Hospital of Llandough, Cardiff, | United Kingdom

Dr Evans is a consultant diabetologist at the university hospital of Llandough in Cardiff, where he has been in post since 2003. He has a very active research interest, particularly in the fields of health economics, health outcomes, epidemiology and pharmacoepidemiology. He has published over 200 peer reviewed papers and abstracts across these fields and has also supported various HTA submissions for differing novel therapies across a variety of disease areas. He is currently editor in chief of Diabetes therapy, a journal specifically focused on therapeutic issues in diabetes.

María Blanco-Prieto

University of Navarra, Navarra, Spain | Spain

Maria Blanco-Prieto, full Professor at the University of Navarra, received her Pharmacy Degree from the University of Santiago de Compostela (Spain), followed by a PhD in Pharmaceutical Sciences from the University of Paris-Sud (France). She completed a post-doctoral training at the Swiss Federal Institute of Technology (ETH), Zürich, (Switzerland) and then joined the University of Navarra as research scientist and associate professor. From January 2006 to August 2013, she was the director of the line of research “Nanotechnologies and Drug Delivery Systems” at the Department of Pharmacy and Pharmaceutical technology, University of Navarra. Her research lay in the field of biomaterials and advanced drug carrier systems including the design and the development of polymer and lipid based micro- and nanoscale carriers, their biological evaluation in in vitro cell cultures (toxicity, mechanism of action, intracellular drug release) and also their pharmacokinetic and dynamic impact in vivo (using relevant animal models of the diseases). These micro and nanosystems are prepared using non-toxic, biocompatible and biodegradable biomaterials. Research carried out in this field is mainly applied to cancer, infectious, cardiovascular and neurodegenerative diseases. The main objectives are to target the molecules to their site of action (i.e. cancer cells), to decreases the toxicity of anticancer drugs, to improve the oral absorption of poorly absorbed drugs, to protect fragile molecules like cytokines (for cardiac tissue regeneration) or neurotrophic factors (for brain tissue regeneration) from degradation in the body and to achieve a controlled and sustained release of the entrapped molecules over the time. She is the author or co-author of more than 145 research papers and book chapters with more than 6.500 cites (H-index 46), 4 editorials, 5 patents and over 180 communications at scientific conferences, many of them as invited speaker. She serves in the editorial board of Journal of Drug Delivery Science and Technology (Formerly STP Pharma Science), European Journal of Pharmaceutics and Biopharmaceutics, International Journal of Pharmaceutics, Journal of Drug Delivery, Recent patents on Nanomedicine, Cancer Letters, Maturitas, Current Bionanotechnology and Molecular Pharmaceutics. Her research in drug delivery has won me numerous awards.

Michael DeCoske, PharmD, BCPS, FASHP,

Assistant Vice President, Pharmacy Administration Baptist Health South Florida | USA

-

Mohammad Alshabeeb, Ph.D.

Clinical Pharmacist, Consultant Pharmacogeneticist Post-doctoral Researcher King Abdullah International Medical Research Center (KAIMRC), Riyadh, | Saudi Arabia

-

Morten Hjulsager,

Former Head of Danish National Board of Health & MoH Denmark, Market Access Director, MSD, Switzerland | Switzerland

-

Nuha Tariq Fairraq, Pharm.D., BCOP

King Abdulaziz Medical City National Guard, Jeddah, Saudi Arabia | Saudi Arabia

-

Oriol Sola-Morales, PhD

CEO of Health Innovation Technology Transfer (HITT) and Former Policy Advisor to the Ministry of Health, | Spain

Dr. Oriol Sola-Morales is an expert in planning, policy and decision-making environment within the healthcare sector. He has been policy advisor to 2 Ministers of Health. In 2011, Oriol founded HITT, a biotech consultancy specialized in Market Access and Technology Transfer. By background, he is a medical doctor specialized in Internal Medicine. He earned an MSc from the London School of Economics and Political Science (LSE) and the London School of Hygiene and Tropical Medicine (LSHTM) and a PhD from Universitat Rovira I Virgili (URV).

Patrick Kilbride

Senior Vice President, US Chamber of Commerce, Global Innovation Policy Center, | USA

-

Peter J. Pitts

President, Center for Medicine in the Public Interest, Former FDA’s Associate Commissioner for External Relations, USA | USA

-

Robert Sindelar

Professor and Dean Emeritus Faculty of Pharmaceutical Sciences | Canada

Dr. Sindelar is a Professor and Dean Emeritus, Faculty of Pharmaceutical Sciences, University of British Columbia (UBC). Dr. Sindelar is also an elected fellow of the Canadian Academy of Health Sciences, and an elected fellow of the International Pharmaceutical Federation (FIP). He is Adjunct Professor of Medicinal Chemistry and Adjunct Research Professor of the Research Institute of Pharmaceutical Sciences, The School of Pharmacy, The University of Mississippi. Currently, he serves as the Chair of the FIP “Global Pharmacy Observatory Data & Intelligence Presidential Commission, to provide strategic advice on the development of the Global Pharmaceutical Observatory working with FIP stakeholders including WHO. He is also the Head of Pharmaceutical Sciences, the Athens Institute for Education and Research. Professor Sindelar previously served as Vice President of Innovation, Research & Academic Affairs at Providence Health Care (PHC), President of the PHC Research Institute and Associate Dean Research in the UBC Faculty of Medicine (2013-2016). He is a founder of the Centre for Drug Research and Development (formerly CDRD, now called adMare BioInnovations), a national not-for-profit drug development and commercialization centre. Also, he has served as President of the Global Drug Commercialization Centre (GDCC)-China, and Vice President, GDCC-Worldwide (2017-2019), a translational medicine endeavor that facilitates the innovative development of healthcare initiatives. In these various roles, he continues to contribute to health science research, health policy development, team-building, international partnerships, as well as strategic innovations. Dr. Sindelar completed a M.S. degree and a Ph.D. in Medicinal Chemistry and Natural Products at the University of Iowa School of Pharmacy. His research expertise is in medicinal chemistry, computer-aided drug discovery, and pharmaceutical biotechnology. He is the recipient of several School and University-wide teaching honors and has co-edited 5 editions of the highly successful textbook entitled “Pharmaceutical Biotechnology: Fundamentals and Applications.”

Salah Abohelaika, Ph.D.

Consultant Clinical Pharmacist/Pharmacogeneticist Qatif Central Hospital, Qatif, | Saudi Arabia

-

Saleh A Alanazi

B.Sc. (Pharm.), M.Sc., Ph.D. TQM, QCPP, CPHQ, CPSO, King Abdulaziz Medical City National Guard Hospital, Ministry of National Guard,Riyad | Saudi Arabia

-

Sara A. Alsayed, Pharm.D., RPh

Clinical Pharmacist, NICU, Security Forces Hospital, Riyadh, Saudi Arabia | Saudi Arabia

-

Sebastien Cochinard

Head of Health Economics, Master Program at Sorbonne University Abu Dhabi & Member of French Health Economists Association, Paris, France | France

-

Thuraya N Bumozah. RPh, M.Sc.

Clinical Pharmacist, Department of Pharmacy, Maternity and Children Hospital, AlAhssa, | Saudi Arabia

-

Zahra AL Qamariat. RPh, M.Sc.

Senior Clinical Pharmacist, Dammam Medical Complex, Kingdom of Saudi Arabia | Saudi Arabia

-